Long Term Depressed Mood Clinical Trial
| NCT number | NCT00226863 |
| Other study ID # | 1HSA698 |
| Secondary ID | |
| Status | Completed |
| Phase | Phase 3 |
| First received | September 12, 2005 |
| Last updated | September 23, 2005 |
| Verified date | September 2005 |
| Source | Stanford University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
This study examined whether meditation or group psychotherapy including hypnosis plus education, compared to an educational control, would ameliorate long-term depressed mood.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Currently meeting DSM-IV criteria for a chronic depressive disorder, with the requirement that depressive symptoms had to have lasted for at least 2 years without a remission of 2 months or more. - Being 18 years of age or older. - Being sufficiently proficient in English to be able to participate in group therapy. - Being able to attend weekly meetings at Stanford. Exclusion Criteria: - Concurrent bipolar disorder or severe depressive disorder (this latter was determined in supervision for the SCID interviews). - Presence or history of psychosis. - A current primary diagnosis of panic disorder, generalized anxiety disorder, or PTSD. - A current primary diagnosis of drug or alcohol dependency or abuse (within the last 3 months). - Serious suicidal risk, as defined by: - Current suicidality, i.e., beyond simple ideation (e.g., making threats or attempts; gathering means; has a plan); OR - Serious prior attempts (bodily harm; gathered means; hospitalization). - Has a significant medical condition that could interfere with participation in meditation/yoga. - Current participation in psychotherapy or a meditation group. - Has started (or changed level or type of) prescribed antidepressant medication or St. John’s Wort in the previous 3 months. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Stanford University |